中国麻风皮肤病杂志 ›› 2022, Vol. 38 ›› Issue (4): 251-252.doi: 10.12144/zgmfskin202204251

• 病例报告 • 上一篇    下一篇

顽固性扁平疣患者接种新型冠状病毒灭活疫苗后皮损自行消退一例

孙右才,孙琦巍   

  1. 许昌市中心医院皮肤科,河南许昌,461000
  • 出版日期:2022-04-15 发布日期:2022-02-10
  • 通讯作者: 孙右才,E-mail: 1394534892@qq.com

Flat warts self-cured in a patient after given COVID-19 vaccination: a case report

SUN Youcai, SUN Qiwei   

  1. Department of Dermatology, Xuchang Central Hospital, Xuchang 461000, China
  • Online:2022-04-15 Published:2022-02-10
  • Contact: SUN Youcai, E-mail: 1394534892@qq.com

摘要: 患者,男,26岁。2年前无明显诱因面部、上肢出现多发扁平丘疹,曾多次就诊于我院,诊断为“扁平疣”给予维A酸类药物外用、CO2点阵激光治疗,效果欠佳。2021年5月13日患者行COVID-19-1(Vero Cell)(新型冠状病毒灭活疫苗-北京生物,批号2021020088)首剂接种,1天后扁平疣皮损变红,自觉瘙痒明显,于2021年5月17日来我院就诊,未予药物治疗,嘱观察,2021年5月23日复诊时疣体枯萎脱落。

关键词: 扁平疣, 新型冠状病毒疫苗COVID-19 Vaccine(Vero Cell)

Abstract: A 26-year-old male presented with flat warts for 2 years, and was given the treatment of retinoids and CO2 lattice laser, with poor therapeutic effect. The Patient was given COVID-19 vaccination (vero cell), Inactivated (Beijing Institute of Biological Products Co., Ltd, Batch Number: 2021020088) on May 13, 2021. The lesions colour turned red, and itching obviously after 1 day of vaccination. No treatment was given when the patient visited the doctor on May 17, 2021. The lesions subsided when the patient visited the doctor on May 23, 2021.

Key words: flat warts, COVID-19 Vaccine